#398 ‒ AMA #86: GLP-1 RAs and muscle loss: new data, better questions, and how to preserve muscle during weight loss
Key claim: Attia argues that when patients on GLP-1 receptor agonists are thoroughly counseled on adequate protein intake and proper resistance training, very little lean mass is lost during weight loss.
Abstract
“When patients are counseled thoroughly on how to consume protein [in the right amount] and how to properly engage in resistance training, we’re seeing very little lean mass lost.” —Peter Attia The post #398 ‒ AMA #86: GLP-1 RAs and muscle loss: new data, better questions, and how to preserve muscle during weight loss appeared first on Peter Attia MD.
Why this matters
Muscle loss is the most prominent longevity-side critique of GLP-1 agonists, and how it is framed in podcasts shapes clinic protocols faster than trial data can. Attia’s synthesis narrows the concern to a conditional one — contingent on protein and resistance training — turning a blanket risk signal into a behavioral prescription, which is itself the trend worth tracking even as the underlying RCT evidence on preserved lean mass remains limited.